新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？ - Suppr

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?

作者信息

Maes Tania, Bracke Ken, Brusselle Guy G

机构信息

Department of Respiratory MedicineGhent University HospitalGent, Belgiumand.

Department of Epidemiology andDepartment of Respiratory MedicineErasmus Medical Center RotterdamRotterdam, the Netherlands.

出版信息

Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.

DOI:10.1164/rccm.202005-1651ED

PMID:32437628

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7328335/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffe6/7328335/d75d8152500d/rccm.202005-1651EDf1.jpg

相似文献

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？

Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?吸入性糖皮质激素与新冠病毒疾病相关死亡率：是混淆因素还是明确因素？

Lancet Respir Med. 2020 Nov;8(11):1065-1066. doi: 10.1016/S2213-2600(20)30447-1. Epub 2020 Sep 24.

Reply to Lipworth : Inhaled Corticosteroids and COVID-19.对利普沃思的回复：吸入性糖皮质激素与2019冠状病毒病

Am J Respir Crit Care Med. 2020 Sep 15;202(6):900-902. doi: 10.1164/rccm.202006-2129LE.

Inhaled Corticosteroids and COVID-19.吸入性糖皮质激素与新型冠状病毒肺炎

Am J Respir Crit Care Med. 2020 Sep 15;202(6):899-900. doi: 10.1164/rccm.202005-2000LE.

Asthma, biologics, corticosteroids, and coronavirus disease 2019.哮喘、生物制剂、皮质类固醇与2019冠状病毒病

Ann Allergy Asthma Immunol. 2020 Jul;125(1):12-13. doi: 10.1016/j.anai.2020.05.001. Epub 2020 May 6.

[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]

Rev Med Liege. 2020;75(S1):130-132.

[Drugs that aggravate the course of COVID-19 : really ?].[加重新型冠状病毒肺炎病程的药物：真的吗？]

Rev Med Suisse. 2020 Apr 29;16(N° 691-2):852-854.

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?病毒大流行中的吸入性糖皮质激素：治疗新型冠状病毒肺炎（COVID-19）的方法？

Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.

Common concerns in managing bronchial asthma during the COVID-19 pandemic.在新冠疫情期间管理支气管哮喘的常见问题。

Int J Tuberc Lung Dis. 2020 Jul 1;24(7):750-752. doi: 10.5588/ijtld.20.0378.

Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend?皮质类固醇在SARS-CoV-2感染中的应用：是敌，还是能成为友？

Pol Arch Intern Med. 2020 Oct 29;130(10):922. doi: 10.20452/pamw.15661.

引用本文的文献

The effect of the COVID-19 pandemic on pediatric asthma-related emergency department visits and hospital admissions in Montréal, Quebec: a retrospective cohort study.魁北克省蒙特利尔市 COVID-19 大流行对儿科哮喘相关急诊就诊和住院的影响：一项回顾性队列研究。

CMAJ Open. 2023 Feb 14;11(1):E152-E159. doi: 10.9778/cmajo.20220072. Print 2023 Jan-Feb.

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection.气道疾病患者对SARS-CoV-2感染的易感性。

Am J Respir Crit Care Med. 2022 Sep 15;206(6):696-703. doi: 10.1164/rccm.202111-2547PP.

Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center.呼吸疾病转诊中心疑似 COVID-19 门诊患者的特征和结局。

Respir Med. 2022 Jun;197:106832. doi: 10.1016/j.rmed.2022.106832. Epub 2022 Apr 7.

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.SARS-CoV-2 大流行背景下慢性呼吸道疾病患者的风险评估：德国呼吸学会与德国胸科医师协会支持的立场声明。

Respiration. 2022;101(3):307-320. doi: 10.1159/000518896. Epub 2022 Jan 21.

COVID-19, Severe Asthma and Omalizumab Therapy: A Case-Based Inquiry into Associations, Management, and the Possibility of a Better Outcome.新型冠状病毒肺炎、重度哮喘与奥马珠单抗治疗：基于病例对关联、管理及改善预后可能性的探究

Turk Thorac J. 2021 Nov;22(6):501-506. doi: 10.5152/TurkThoracJ.2021.20329.

An Analysis of Demographics and Inhaled Corticosteroid Use on COVID-19 Outcomes Among Hospitalized Adult Asthmatics: An Early Experience at a NY Hospital System.住院成年哮喘患者中人口统计学因素及吸入性糖皮质激素使用情况对COVID-19预后的分析：纽约医院系统的早期经验

J Asthma Allergy. 2021 Dec 10;14:1473-1484. doi: 10.2147/JAA.S337518. eCollection 2021.

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19.皮质类固醇疗法对哮喘和慢性阻塞性肺疾病患者预防新型冠状病毒肺炎的潜在保护作用。

Clin Mol Allergy. 2021 Nov 1;19(1):19. doi: 10.1186/s12948-021-00159-4.

Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization.因新型冠状病毒肺炎（COVID-19）入住急诊科的患者中的哮喘：患病率及住院风险

Intern Emerg Med. 2022 Apr;17(3):917-920. doi: 10.1007/s11739-021-02868-9. Epub 2021 Oct 17.

COVID-19 and COPD: lessons beyond the pandemic.新冠病毒肺炎与慢性阻塞性肺疾病：疫情之外的教训

Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L978-L982. doi: 10.1152/ajplung.00386.2021. Epub 2021 Sep 29.

Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease.香烟烟雾和 COPD 对 SARS-CoV-2 感染和疾病的矛盾影响。

BMC Pulm Med. 2021 Aug 23;21(1):275. doi: 10.1186/s12890-021-01639-8.

本文引用的文献

Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.吸入性皮质类固醇与 COVID-19：系统回顾与临床观察。

Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.01009-2020. Print 2020 May.

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.吸烟会增加严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的受体血管紧张素转换酶2（ACE2）在肺部的基因表达。

Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559. doi: 10.1164/rccm.202003-0693LE.

COVID-19 with Different Severities: A Multicenter Study of Clinical Features.不同严重程度的 COVID-19：一项多中心临床特征研究。

Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达：对 COVID-19 的影响。

Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.

Pathogenesis of COVID-19 from a cell biology perspective.从细胞生物学角度看 COVID-19 的发病机制。

Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.00607-2020. Print 2020 Apr.

Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).吸烟上调血管紧张素转换酶2受体：新型冠状病毒SARS-CoV-2（新冠病毒）的潜在粘附位点。

J Clin Med. 2020 Mar 20;9(3):841. doi: 10.3390/jcm9030841.

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。

Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。

Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结

JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献